Fundraising Fox

Adamis Pharmaceuticals

San Diego, US · Delaware corporation

Biotech

Founders & leadership

KK
Karen K DanielsExecutive
RO
Robert O HopkinsExecutive
RB
Ronald B MossExecutive
DJ
Dennis J CarloNamed on SEC filing
RC
Richard C WilliamsNamed on SEC filing
HB
Howard BirndorfNamed on SEC filing
RB
Roshawn BluntNamed on SEC filing
DJ
David J MarguglioNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$7M disclosed across 3 of 4 rounds · 2020–2023

▶Undisclosed amountofferedJun 2023 · 12 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Meera J. DesaiDirector
  • Howard BirndorfDirector
  • Ebrahim VersiExecutive Officer, Director
  • Vickie S. ReedDirector
  • David J. MarguglioExecutive Officer
  • Jannine VersiDirector
  • David C. BenedictoExecutive Officer
First sale
May 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$300KraisedJul 2022 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Howard BirndorfDirector
  • Vickie S. ReedDirector
  • Meera J. DesaiDirector
  • David MarguglioExecutive Officer, Director
  • Richard C. WilliamsDirector
  • Ronald B. MossExecutive Officer
  • David C. BenedictoExecutive Officer
Offering amount
$300K
Amount sold
$300K
First sale
Jul 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$590KraisedJun 2020 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Ronald B MossExecutive Officer
  • David J MarguglioExecutive Officer, Director
  • Richard C WilliamsDirector
  • Karen K DanielsExecutive Officer
  • Roshawn BluntDirector
  • Dennis J CarloExecutive Officer, Director
  • Robert O HopkinsExecutive Officer
  • Howard BirndorfDirector
Offering amount
$590K
Amount sold
$590K
First sale
Jun 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.1MraisedMar 2020 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Karen K DanielsExecutive Officer
  • Robert O HopkinsExecutive Officer
  • Ronald B MossExecutive Officer
  • Dennis J CarloExecutive Officer, Director
  • Richard C WilliamsDirector
  • Howard BirndorfDirector
  • Roshawn BluntDirector
  • David J MarguglioExecutive Officer, Director
Offering amount
$6.1M
Amount sold
$6.1M
Placement agents
Maxim Group LLC
First sale
Feb 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Adamis Pharmaceuticals raised?
Adamis Pharmaceuticals has disclosed $7M raised across 3 of its 4 known rounds.
Where is Adamis Pharmaceuticals headquartered?
Adamis Pharmaceuticals is headquartered in San Diego, US.